We have previously reported that the non-psychoactive component of Cannabis sativa, cannabidiol (CBD), provided neuroprotection against Aβ42-mediated inhibition of LTP in an acute in vitro model of AD [11]; a potential mechanism of action is via peroxisome proliferator active receptor gamma (PPARγ). This evidence concerns the gene PPARG and Alzheimer disease.